|Welcome to Mediscript: Providing innovation, imagination, inspiration and integrity|
The 19th Annual Resistance and Antiviral Therapy Meeting was held at the Wellcome Collection in London on Wednesday 16 September 2015. Our international speakers included Professor Andrea De Luca, Dr Miriam Lichtner, Dr José Luis Blanco Arévalo and Dr Marije Hofstra.
Delegate feedback reported that the programme contained highly qualified speakers who provided updates on the very latest information/research. In total over 100 delegates registered for the meeting. This number included 3 student scholarship winners and 3 community registration places.
A year in review. HIV and HIV co-infection with HCV: scientific advances that will change clinical practice
Session 1: Virological aspects of HIV pathogenesis
Is cytomegalovirus a significant co-factor in HIV infection and disease?
How is the HIV reservoir maintained during long-term ART?
Session 2: Virological aspects of HIV therapy
Host cell antivirals: ideas for the next pipeline?
Is drug resistance a threat to PrEP programmes?
What is new on resistance to the integrase inhibitors?
The influence of HIV on HCV: from virus replication to treatment outcomes
Session 3: UK research in progress: HIV and co-infections
10-minute presentations of emerging data
Evolution of HIV-1 under interferon-alpha treatment
Global epidemiology of drug resistance following failure of tenofovir-containing WHO recommended regimens for adult HIV-1 infection
Does subtype C virus increase the risk of virological failure on first-line TDF-containing regimens?
Long-term virological outcomes among ART-experienced patients receiving raltegravir in a large European cohort study
Treatment-emergent resistance during prolonged failure of NNRTI-based ART
The impact of HLA Class I on virological outcomes of HBV infection
Resistance variants in HCV-infected patients receiving all-oral therapy
Exploring the interaction of HIV with human endogenous retroviruses
Session 4: Debates in HIV care
Which single-tablet regimen for which patient?
Which level of plasma viral load for defining virological failure?
Professor Anna Maria Geretti, Institute of Infection and Global Health, University of Liverpool
Continuing Professional Development (CPD)
Medical staff in career-grade posts who are enrolled with one of the Federation of Royal Colleges for Continuing Professional Development can receive CPD credits at the rate of one CPD credit per hour (exclusive of travel, refreshments or social activities). The conference has been allocated 6 CPD credits with the unique reference code: 98848. Certificates for attendance were supplied in the conference pack that was handed to you at the registration desk.